% | $
Quotes you view appear here for quick access.

Cubist Pharmaceuticals Inc. Message Board

  • txplunger txplunger Jul 19, 2007 1:04 PM Flag

    RBC Says Takeover Target

    Cubist Pharma: Color on quarter (19.99 ) : RBC notes CBST reported upside Q2 US rev of $68 mln vs their expectation of $63 mln. Firm reiterates their Outperform and have increased confidence in Cubicin's growth trajectory and outer year sales forecasts. Cubicin sales and co profitability were well ahead of expectations, and the co increased 2007 sales guidance. Firm has raised their sales forecast to the mid-point of the revised guidance, but believe upside to their forecast is possible. Importantly, they have increased confidence in their 2008 Cubicin forecast. Firm continues to view Cubist as a value stock and a potential acquisition target, especially after a robust quarter that supports strong demand for the product. Firm's new 2007 Cubicin forecast is $273 mln, up from $264 mln, and their 2008 forecast is unchanged at $327 mln...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Thanks for posting RBC's note.

      I listened to the CC last night and have listened to several previous webcasts.

      CBST is the best risk reward story that I know of. It is cheap. If it doesn't move substantially higher, it almost certainly will be taken over (IMHO). I'll be being buying more on any pull back.